PACE GARY W
Insider CIK 1184778 · CRDF Director · PCRX Director · RMD Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRDF Cardiff Oncology, Inc. | P Buy deriv | 2026-07-14 | 2026-07-16 | 687,285 | — | $0 | 687,285 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2026-07-14 | 2026-07-16 | 687,285 | $1.46 | $1.00M | 2,043,661 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2026-06-18 | 2026-06-22 | 30,000 | $1.22 | $36.6K | 1,356,376 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2026-06-11 | 2026-06-15 | 40,565 | — | $0 | 228,104 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2025-07-30 | 2025-07-31 | 15,000 | $2.45 | $36.8K | 1,345,676 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2025-07-30 | 2025-07-31 | 275,000 | $2.45 | $673.8K | 1,330,676 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2025-06-26 | 2025-06-27 | 40,565 | — | $0 | 187,539 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2024-12-11 | 2024-12-12 | 350,115 | $2.60 | $910.3K | 1,047,876 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2024-12-11 | 2024-12-12 | 11,500 | $2.60 | $29.9K | 1,059,376 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2024-06-27 | 2024-07-01 | 29,700 | — | $0 | 146,974 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2024-03-08 | 2024-03-08 | 90,000 | $30.60 | $2.75M | 22,127 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2024-03-07 | 2024-03-08 | 28,257 | $30.81 | $870.6K | 112,127 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2024-03-06 | 2024-03-08 | 1,066 | $29.67 | $31.6K | 140,384 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2023-12-19 | 2023-12-19 | 30,000 | $1.37 | $41.1K | 697,761 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2023-11-10 | 2023-11-14 | 22,950 | $0.98 | $22.5K | 667,761 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 27,700 | — | $0 | 117,274 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 12,925 | — | $0 | 12,925 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award | 2023-06-14 | 2023-06-16 | 1,775 | — | $0 | 141,450 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2023-05-11 | 2023-05-15 | 7,000 | — | $0 | 0 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2023-05-11 | 2023-05-15 | 5,015 | $41.78 | $209.5K | 139,675 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2023-05-11 | 2023-05-15 | 7,000 | $29.90 | $209.3K | 144,690 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2022-09-15 | 2022-09-19 | 150,000 | $1.71 | $256.5K | 644,811 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2022-06-08 | 2022-06-08 | 8,225 | — | $0 | 8,225 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award | 2022-06-08 | 2022-06-08 | 1,160 | — | $0 | 137,690 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2022-03-09 | 2022-03-11 | 26,800 | — | $0 | 89,574 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2022-03-03 | 2022-03-07 | 7,000 | — | $0 | 0 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2022-03-03 | 2022-03-07 | 7,000 | $10.81 | $75.7K | 136,530 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2022-03-01 | 2022-03-01 | 193 | — | $0 | 0 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2022-03-01 | 2022-03-01 | 1,166 | — | $0 | 0 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2022-03-01 | 2022-03-01 | 1,359 | $67.75 | $92.1K | 129,530 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2022-03-01 | 2022-03-01 | 1,166 | $11.02 | $12.8K | 130,889 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2022-03-01 | 2022-03-01 | 193 | $11.02 | $2.1K | 129,723 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2022-02-28 | 2022-03-01 | 18,834 | — | $0 | 1,166 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2022-02-28 | 2022-03-01 | 9,807 | — | $0 | 193 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2022-02-28 | 2022-03-01 | 9,807 | $11.02 | $108.1K | 139,337 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2022-02-28 | 2022-03-01 | 18,834 | $11.02 | $207.6K | 158,171 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2022-02-28 | 2022-03-01 | 28,641 | $66.83 | $1.91M | 129,530 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2021-09-21 | 2021-09-22 | 30,000 | $6.75 | $202.5K | 494,811 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2021-06-10 | 2021-06-14 | 22,000 | — | $0 | 62,774 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2021-06-09 | 2021-06-11 | 7,626 | — | $0 | 7,626 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award | 2021-06-09 | 2021-06-11 | 1,066 | — | $0 | 129,530 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | G Gift | 2021-05-13 | 2021-06-11 | 1,485 | — | $0 | 128,464 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2021-03-23 | 2021-03-24 | 5,000 | $10.20 | $51.0K | 459,811 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2021-03-23 | 2021-03-24 | 2,500 | $10.31 | $25.8K | 464,811 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2021-03-23 | 2021-03-24 | 2,500 | $10.21 | $25.5K | 462,311 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2021-03-18 | 2021-03-19 | 2,000 | $10.54 | $21.1K | 454,811 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2021-03-18 | 2021-03-19 | 1,000 | $10.58 | $10.6K | 452,811 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2021-03-04 | 2021-03-04 | 1,500 | $9.27 | $13.9K | 451,811 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2020-09-25 | 2020-09-29 | 70,000 | — | $0 | 0 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2020-09-25 | 2020-09-29 | 70,000 | $16.67 | $1.17M | 129,949 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2020-09-16 | 2020-09-17 | 1,700 | $5.69 | $9.7K | 449,461 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2020-09-16 | 2020-09-17 | 850 | $5.71 | $4.9K | 450,311 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2020-06-17 | 2020-06-19 | 28,858 | — | $0 | 40,774 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 8,027 | — | $0 | 8,027 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award | 2020-06-09 | 2020-06-11 | 1,260 | — | $0 | 59,949 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2020-05-11 | 2020-05-13 | 447,761 | $1.34 | $600.0K | 447,761 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2020-04-16 | 2020-05-01 | 11,916 | — | $0 | 11,916 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2020-03-12 | 2020-03-16 | 7,438 | — | $0 | 0 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2020-03-12 | 2020-03-16 | 4,649 | — | $0 | 0 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2020-03-12 | 2020-03-16 | 5,000 | — | $0 | 0 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2020-03-12 | 2020-03-16 | 4,649 | — | $0 | 0 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2020-03-12 | 2020-03-16 | 7,438 | $1.61 | $12.0K | 53,689 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2020-03-12 | 2020-03-16 | 5,000 | $13.98 | $69.9K | 58,689 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2020-03-12 | 2020-03-16 | 4,649 | $1.61 | $7.5K | 41,602 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2020-03-12 | 2020-03-16 | 4,649 | $1.61 | $7.5K | 46,251 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2019-06-05 | 2019-06-06 | 8,437 | — | $0 | 8,437 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award | 2019-06-05 | 2019-06-06 | 4,134 | — | $0 | 36,953 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | P Buy | 2018-11-19 | 2018-11-21 | 4,500 | $46.18 | $207.8K | 32,819 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | P Buy | 2018-11-07 | 2018-11-09 | 4,000 | $51.29 | $205.2K | 28,319 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2018-06-13 | 2018-06-15 | 4,693 | — | $0 | 4,693 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award | 2018-06-13 | 2018-06-15 | 782 | — | $0 | 24,319 | SEC↗ |
| RMD RESMED INC | M Exercise deriv | 2018-05-08 | 2018-05-10 | 28,403 | — | $0 | 0 | SEC↗ |
| RMD RESMED INC | S Sale | 2018-05-08 | 2018-05-10 | 28,403 | $97.37 | $2.77M | 100,578 | SEC↗ |
| RMD RESMED INC | M Exercise | 2018-05-08 | 2018-05-10 | 28,403 | $27.58 | $783.4K | 128,981 | SEC↗ |
| RMD RESMED INC | A Award | 2017-11-16 | 2017-11-17 | 2,991 | — | $0 | 100,578 | SEC↗ |
| RMD RESMED INC | M Exercise deriv | 2017-06-15 | 2017-06-16 | 22,660 | — | $0 | 0 | SEC↗ |
| RMD RESMED INC | M Exercise | 2017-06-15 | 2017-06-16 | 22,660 | $33.70 | $763.6K | 120,247 | SEC↗ |
| RMD RESMED INC | S Sale | 2017-06-15 | 2017-06-16 | 22,660 | $76.00 | $1.72M | 97,587 | SEC↗ |
| RMD RESMED INC | M Exercise deriv | 2017-06-14 | 2017-06-16 | 1,730 | — | $0 | 22,660 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2017-06-14 | 2017-06-16 | 2,714 | — | $0 | 2,714 | SEC↗ |
| RMD RESMED INC | M Exercise | 2017-06-14 | 2017-06-16 | 1,730 | $33.70 | $58.3K | 99,317 | SEC↗ |
| RMD RESMED INC | S Sale | 2017-06-14 | 2017-06-16 | 1,730 | $76.00 | $131.5K | 97,587 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award | 2017-06-14 | 2017-06-16 | 1,357 | — | $0 | 23,537 | SEC↗ |
| RMD RESMED INC | A Award | 2016-11-16 | 2016-11-17 | 4,429 | — | $0 | 97,587 | SEC↗ |
| RMD RESMED INC | M Exercise deriv | 2016-08-19 | 2016-08-22 | 36,000 | — | $0 | 0 | SEC↗ |
| RMD RESMED INC | M Exercise | 2016-08-19 | 2016-08-22 | 36,000 | $25.54 | $919.4K | 129,158 | SEC↗ |
| RMD RESMED INC | S Sale | 2016-08-19 | 2016-08-22 | 36,000 | $69.93 | $2.52M | 93,158 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2016-06-15 | 2016-06-17 | 2,975 | — | $0 | 2,975 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award | 2016-06-15 | 2016-06-17 | 1,488 | — | $0 | 22,180 | SEC↗ |
| RMD RESMED INC | M Exercise deriv | 2016-03-11 | 2016-03-14 | 36,000 | — | $0 | 0 | SEC↗ |
| RMD RESMED INC | S Sale | 2016-03-11 | 2016-03-14 | 36,000 | $60.00 | $2.16M | 93,158 | SEC↗ |
| RMD RESMED INC | M Exercise | 2016-03-11 | 2016-03-14 | 36,000 | $23.88 | $859.7K | 129,158 | SEC↗ |
| RMD RESMED INC | A Award deriv | 2015-11-19 | 2015-11-23 | 20,492 | — | $0 | 20,492 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2015-06-03 | 2015-06-05 | 4,000 | — | $0 | 4,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award | 2015-06-03 | 2015-06-05 | 2,000 | — | $0 | 20,692 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | P Buy | 2015-03-13 | 2015-03-17 | 1,000 | $93.83 | $93.8K | 18,692 | SEC↗ |
| RMD RESMED INC | M Exercise deriv | 2015-01-26 | 2015-01-28 | 48,000 | — | $0 | 0 | SEC↗ |
| RMD RESMED INC | M Exercise | 2015-01-26 | 2015-01-28 | 48,000 | $16.50 | $792.0K | 141,158 | SEC↗ |
| RMD RESMED INC | S Sale | 2015-01-26 | 2015-01-28 | 48,000 | $66.77 | $3.20M | 93,158 | SEC↗ |
| RMD RESMED INC | A Award | 2014-11-19 | 2014-11-21 | 4,885 | — | $0 | 4,885 | SEC↗ |
| RMD RESMED INC | M Exercise deriv | 2014-08-18 | 2014-08-20 | 36,000 | — | $0 | 0 | SEC↗ |
| RMD RESMED INC | M Exercise | 2014-08-18 | 2014-08-20 | 36,000 | $21.03 | $757.1K | 113,273 | SEC↗ |
| RMD RESMED INC | S Sale | 2014-08-18 | 2014-08-20 | 25,000 | $51.60 | $1.29M | 88,273 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2014-06-03 | 2014-06-05 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RMD RESMED INC | M Exercise deriv | 2014-02-18 | 2014-02-20 | 48,000 | — | $0 | 0 | SEC↗ |
| RMD RESMED INC | M Exercise | 2014-02-18 | 2014-02-20 | 48,000 | $12.74 | $611.5K | 125,273 | SEC↗ |
| RMD RESMED INC | S Sale | 2014-02-18 | 2014-02-20 | 48,000 | $46.06 | $2.21M | 77,273 | SEC↗ |
| RMD RESMED INC | A Award deriv | 2013-11-13 | 2013-11-15 | 20,713 | — | $0 | 20,713 | SEC↗ |
| RMD RESMED INC | M Exercise deriv | 2013-09-09 | 2013-09-11 | 12,000 | — | $0 | 0 | SEC↗ |
| RMD RESMED INC | M Exercise | 2013-09-09 | 2013-09-11 | 12,000 | $23.10 | $277.2K | 89,273 | SEC↗ |
| RMD RESMED INC | S Sale | 2013-09-09 | 2013-09-11 | 12,000 | $50.05 | $600.6K | 77,273 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2013-06-12 | 2013-06-14 | 7,000 | — | $0 | 7,000 | SEC↗ |
| RMD RESMED INC | A Award deriv | 2012-11-15 | 2012-11-19 | 25,934 | — | $0 | 25,934 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2012-08-17 | 2012-08-21 | 70,000 | — | $0 | 70,000 | SEC↗ |
| RMD RESMED INC | M Exercise deriv | 2012-08-07 | 2012-08-09 | 48,000 | — | $0 | 0 | SEC↗ |
| RMD RESMED INC | S Sale | 2012-08-07 | 2012-08-09 | 48,000 | $36.00 | $1.73M | 77,273 | SEC↗ |
| RMD RESMED INC | M Exercise | 2012-08-07 | 2012-08-09 | 48,000 | $9.80 | $470.4K | 125,723 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2012-06-05 | 2012-06-07 | 7,000 | — | $0 | 7,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | P Buy | 2012-04-17 | 2012-04-17 | 10,000 | $9.75 | $97.5K | 17,692 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2012-04-03 | 2012-04-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2012-04-03 | 2012-04-05 | 20,000 | — | $0 | 30,000 | SEC↗ |
| RMD RESMED INC | M Exercise deriv | 2012-01-27 | 2012-01-31 | 48,000 | — | $0 | 0 | SEC↗ |
| RMD RESMED INC | M Exercise | 2012-01-27 | 2012-01-31 | 48,000 | $6.81 | $326.9K | 125,273 | SEC↗ |
| RMD RESMED INC | S Sale | 2012-01-27 | 2012-01-31 | 48,000 | $30.00 | $1.44M | 77,273 | SEC↗ |